跳至主要内容
临床试验/NL-OMON41433
NL-OMON41433已完成不适用

The effect of chemotherapy on coagulation in patients with locally advanced or metastasized pancreatic cancer - Effect of chemotherapy on coagulation

Academisch Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Ductal adenocarcinoma of the pancreas confirmed by histology or cytology
  • Locally advanced or metastasized disease
  • Planned for first line FOLFIRINOX chemotherapy with or without CCX872-B
  • Chemotherapy naïve
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
  • 18 years of age or older
  • Fully capable of making health related decisions
  • Written informed consent

排除标准

  • Current prophylactic or therapeutic anticoagulant therapy
  • Current use of anti-inflammatory drugs
  • Renal insufficiency with estimated glomerular filtration rate < 30 mL/min before start of chemotherapy
  • Venous thromboembolism < 3 months prior to chemotherapy

研究者

相似试验